Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q3 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了公司目前正处于一个明确的等待期,并且为此自掏腰包支付成本,而收益尚未到来,且等待期的结束是一个具体的、临近的、已经可见的事件。 分析记录内容: 1. 关于Laerdal协议:管理层提到与Laerdal的HeartCode和RQI产品协议将于2018年12月31日到期,之后公司将失去销售这些产品的权利。他们计划在2019年1月推出新的复苏解决方案,并已签署了两个新的战略合作伙伴。这似乎是一个过渡期,但公司目前仍在销售现有产品,并从中获得收入,并非“支付成本而无所获”。他们提到新产品的利润率更高,但尚未推出。这更像是一个未来的产品转型,而非当前正在承担成本等待收益。 2. 关于ASC 606合规:管理层提到在第四季度将产生约60万美元的合规成本,这是为了实施新的收入确认标准。这确实是一项当前成本,但它是为了合规,而非等待某个收益事件。而且它是一次性成本,并非持续等待。 3. 关于患者体验业务转型:从电话调查转向在线调查,虽然价格点较低但利润率更高。这似乎是一个正在进行的转型,但公司已经在从在线调查中获得收入,并非“支付成本而无所获”。 4. 关于Provider Solutions从安装软件转向SaaS:这可能导致收入增长放缓,但公司正在从SaaS中获得收入,并非等待。 5. 关于新产品的开发:如Nurse Residency Pathway和OB Risk,这些产品已经产生了一些收入和销售,并非等待。 6. 关于资本支出:增加了软件开发的资本支出,但这是投资于增长,并非等待。 关键点:管理层提到“我们正在为2019年1月推出新复苏解决方案做准备”,但当前仍在销售现有产品,没有描述当前正在承担成本而收益未至的情况。他们提到“我们将在2019年1月推出新复苏解决方案”,但这是未来的事,当前没有描述正在支付成本等待。 此外,管理层提到“我们正在为ASC 606合规支付成本”,但这是合规成本,不是等待收益。 因此,没有明确描述一个“当前正在支付成本,收益未至,且等待期结束是具体事件”的情况。管理层更多是在描述业务转型和未来计划,而非当前承担成本等待。 所以答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.